venBio Global Strategic GP II, L.P.
CIK 1729409 · last filed 2021-04-26
venBio Global Strategic GP II, L.P. is a corporate insider who has filed 6 SEC Form 4 insider transactions across 3 companies since 2019. The most recent filing, for IMPL, was dated Apr 26, 2021. Across all open-market trades the lifetime net is +$26.2M, making them a net buyer over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
3
6
$26.23M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| IPI Legacy Liquidation Co (IMPL) Delisted | 10%+ Owner | — | $0.24 | — | $0 | 1 | 2021-04-26 |
| Checkmate Pharmaceuticals, Inc. (CMPI) Delisted | 10%+ Owner | 3,473,374 | $10.50 | $36.47M | $15.00M | 1 | 2020-08-12 |
| Akero Therapeutics, Inc. (AKRO) Delisted | 10%+ Owner | 3,229,548 | $54.65 | $176.49M | $11.23M | 4 | 2020-02-27 |
Recent Filings
6 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-04-26 | IPI Legacy Liquidation Co (IMPL) Delisted | Other (J) | — | $0 | EDGAR |
| 2020-08-12 | Checkmate Pharmaceuticals, Inc. (CMPI) Delisted | Mixed | +18,366,870 | $15.00M | EDGAR |
| 2020-02-27 | Akero Therapeutics, Inc. (AKRO) Delisted | Sell (S) | −29,520 | -$673.2K | EDGAR |
| 2020-02-10 | Akero Therapeutics, Inc. (AKRO) Delisted | Sell (S) | −30,510 | -$824.8K | EDGAR |
| 2020-01-08 | Akero Therapeutics, Inc. (AKRO) Delisted | Sell (S) | −366,105 | -$7.27M | EDGAR |
| 2019-06-25 | Akero Therapeutics, Inc. (AKRO) Delisted | Mixed | +19,774,290 | $20.00M | EDGAR |